TKM-Ebola
id:
tkm-ebola-22-14858
title:
TKM-Ebola
text:
TKM-Ebola was an experimental antiviral drug for Ebola disease that was developed by Arbutus Biopharma in Vancouver, Canada. The drug candidate was formerly known as Ebola-SNALP. TKM-Ebola is a combination of small interfering RNAs targeting three of the seven proteins in Ebola virus: Zaire Ebola L polymerase, Zaire Ebola membrane-associated protein (VP24), and Zaire Ebola polymerase complex protein (VP35). By down-regulating these three proteins, TKM-Ebola inhibits virus replication and elimina
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental antiviral drug for Ebola disease that failed
original url:
https://en.wikipedia.org/wiki/TKM-Ebola
date created:
date modified:
2023-11-23T22:51:57Z
main entity:
{"identifier":"Q1055750","url":"https://www.wikidata.org/entity/Q1055750"}
image:
fields total:
13
integrity:
14